Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
27.16
-0.10 (-0.37%)
Oct 12, 2026, 11:28 AM EDT - Market open
Zenas BioPharma Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Zenas BioPharma stock has a consensus rating of "Strong Buy" and an average price target of $47.88. The average 1-year stock price forecast is 76.29% higher than the current stock price, while the lowest is $32 (+17.82%) and the highest is $59 (+117.23%).
Price Target: $47.88 (+76.29%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zenas BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $41 → $48 | Buy | Maintains | $41 → $48 | +76.73% | Sep 30, 2026 |
| Wedbush | Wedbush | Buy Maintains $45 | Buy | Maintains | $45 | +65.68% | Sep 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $44 | Buy | Reiterates | $44 | +62.00% | Sep 30, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $22 → $32 | Hold | Maintains | $22 → $32 | +17.82% | Aug 17, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $55 | Buy | Reiterates | $55 | +102.50% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
12.26M
from 10.00M
Increased by 22.60%
Revenue Next Year
57.93M
from 12.26M
Increased by 372.53%
EPS This Year
-5.62
from -4.83
EPS Next Year
-4.66
from -5.62
EPS and Forward PE are based on non-GAAP adjusted numbers.